Illuminating the druggability of the Giardia duodenalis kinome through reannotation and high-throughput screens
- Author(s)
- Lam, AYF; Lucet, IS; Jex, AR; Emery-Corbin, SJ;
- Journal Title
- International Journal for Parasitology Drugs and Drug Resistance
- Publication Type
- Oct 4
- Abstract
- Giardia duodenalis (syn Giardia intestinalis, Giardia lamblia) is a neglected, microaerophilic gastrointestinal parasite reliant on broad spectrum anti-microaerophilic/-anaerobic nitroheterocyclic antibiotics (metronidazole) which have been in use for over 70 years. New drugs which avoid their predecessor's shortfalls of toxic and adverse effects, as well as circumvent its increasing treatment failure, are urgently required to lower global rates of up to 200 million symptomatic cases annually. Kinases are essential regulatory enzymes that primarily catalyse the phosphorylation post-translational modification involved in dynamic cellular processes. Kinases are well-validated and attractive drug targets, with many kinase inhibitors demonstrating great success in the clinic as anticancer therapeutics. In G. duodenalis, its intriguing set of minimal "core" protein kinases and the highly expanded Giardia-specific Never-in-Mitosis-A related kinases (Neks) emerge as a novel druggable space. We propose this kinome as an understudied and underutilised space to explore novel antigiardial targets. Intriguingly, despite over 15 years of advances in kinase biology and new annotation tools, there are limited functional evidence on the existence of 'Neks' in G. duodenalis. To incentivise new efforts, we provide an updated kinome reannotation and examination of the giardial core and specific sub-kinomes using novel bioinformatic tools, suggesting a nomenclature and providing insights in a drug-discovery context. Lastly, we have conducted a high-throughput screening of 430 compounds, covering 53 kinase targets and 51 chemical scaffolds, identifying 83/430 antigiardial kinase inhibitors of which 33 true positives could be validated in a subset subjected to drug-susceptibility testing, highlighting intriguing spaces for further development and molecular probes to further explore kinase regulatory pathways in this parasite.
- Publisher
- Elsevier
- Keywords
- Antiparasitics; Chemotherapeutics; Gastrointestinal parasite; Giardia duodenalis; Kinase
- Research Division(s)
- Infection and Global Health; New Medicines and Diagnostics; Advanced Technology and Biology
- PubMed ID
- 41067048
- Publisher's Version
- https://doi.org/10.1016/j.ijpddr.2025.100619
- Open Access at Publisher's Site
https://doi.org/100619. doi: 10.1016/j.ijpddr.2025.100619- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-10-20 01:57:45
Last Modified: 2025-10-20 01:57:58